Zoetis (ZTS) has a profit margin of 27.79%, above the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Zoetis (ZTS) currently reports a profit margin of 27.79% as of March 2026. That compares with 27.12% in the prior-year period — up 2.5% year over year. That is above the Healthcare sector average of 15.29%. Use the charts on this page to explore Zoetis's profit margin history and peer comparisons.
Zoetis's profit margin increased from 27.12% to 27.79% — a 2.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zoetis's profit margin of 27.79% is higher than the Healthcare sector average of 15.29%. That is roughly 81.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Zoetis's current 27.79% should be judged against Healthcare norms (sector average: 15.29%) and against ZTS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 27.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Zoetis, and consider following ZTS for alerts when major investors trade the stock.